Bigul

GUJARAT INJECT (KERALA) LTD. - 524238 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyGUJARAT INJECT (KERALA) LTD. 2CIN NO.L18100KL1991PLC005926 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.41 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Murli Nair Designation: Compliance Officer EmailId: gikl2015@hotmail.com Name of the Chief Financial Officer: Murli Nair Designation: Chief Financial Officer EmailId: gikl2015@hotmail.com Date: 29/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
29-04-2023
Bigul

GUJARAT INJECT (KERALA) LTD. - 524238 - Submission Of Compliance Certificate In Pursuance Of Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

With reference to captioned subject, please find attached herewith the Compliance Certificate in pursuance of Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 certifying the compliance of requirement of Regulation 7(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2023.
17-04-2023
Bigul

GUJARAT INJECT (KERALA) LTD. - 524238 - Revised Certificate Of Practicing Company Secretary Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

With reference to the captioned subject and as per the requirement of the provisions of Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Revised Certificate from the Practicing Company Secretary for year ended on March 31, 2023 as there was some typographical error in the previous certificate.
17-04-2023
Bigul

GUJARAT INJECT (KERALA) LTD. - 524238 - Submission Of Certificate Of Practicing Company Secretary Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

With reference to the captioned subject and as per the requirement of the provisions of Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Certificate from the Practicing Company Secretary for year ended on March 31, 2023.
15-04-2023
Bigul

GUJARAT INJECT (KERALA) LTD. - 524238 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We submit herewith the confirmation certificate and Details of Share certificates Dematerialized for the period ended on March 31, 2023, received from Bigshare Services Private Limited, Registrar and Share Transfer Agent (RTA) of the Company as per regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2023.
15-04-2023
Bigul

GUJARAT INJECT (KERALA) LTD. - 524238 - Closure of Trading Window

The trading window for dealing in Equity Shares of the Company by the Insiders covered under Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities will be closed from Saturday, April 1, 2023 till 48 hours after the declaration and publication of Financial Results for the quarter ended March 31, 2023.
31-03-2023
Bigul

GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On March 31, 2023,

we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on March 31, 2023, at the Administrative Office of the Company which was commenced at 02:00 P.M. and concluded at 02:30 P.M., has, inter alia, apart from other business, considered and approved; 1. Appointed Mr. Anand Lavingia, Practicing Company Secretary as Secretarial Auditor of the Company for obtaining the Secretarial Audit Report for the financial year 2022-23 (brief Profile of Mr. Anand Lavingia is attached herewith as Annexure 1); 2. Appointed Mr. Ravirajsinh Gohil partner of M/s. R B Gohil & Co. as Internal Auditor of the Company for the financial year 2023-24 (brief Profile of Mr. Ravirajsinh Gohil is attached herewith as Annexure 2).
31-03-2023
Bigul

GUJARAT INJECT (KERALA) LTD. - 524238 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

The meeting of the Board of Directors of the Company was held on today i.e. on March 15, 2023 in which Board Took note of Resignation of Mr. Monil Rajeshbhai Shah, the Company Secretary and Compliance Officer w.e.f March 15, 2023, due to his personal reasons.
15-03-2023
Bigul

GUJARAT INJECT (KERALA) LTD. - 524238 - Results- Financial Results For 31/12/2022

In reference to captioned subject and pursuant to Regulation 33 (3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the followings: 1. Unaudited Financial Results for the quarter ended on December 31, 2022; 2. Limited Review Report. Kindly take the same on your record and disseminate the same on your website and oblige us.
10-02-2023
Bigul

GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On February 10, 2023, In Terms Of Second Proviso To Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on February 10, 2023, at the Administrative Office of the Company which was commenced at 04:30 PM and concluded at 05:00 PM, has apart from other businesses, considered, approved and taken on record the Unaudited Financial Result of the Company for the quarter ended on December 31, 2022 along with Limited Review Report.
10-02-2023
Next Page
Close

Let's Open Free Demat Account